Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Newly Diagnosed Glioblastoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07143812
What this trial is testing

Evaluate the Safety of a Stem Cell-Based Gene and Cell Therapy in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma (GBM)Newly Diagnosed Glioblastoma Multiforme
CHA University 10
Testing effectiveness (Phase 2)Study completedNCT00720356
What this trial is testing

Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

Who this might be right for
Brain and Central Nervous System Tumors
Northwestern University 115
Testing effectiveness (Phase 2)Study completedNCT00124657
What this trial is testing

Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma

Who this might be right for
Brain and Central Nervous System Tumors
St. Jude Children's Research Hospital 62
Large-scale testing (Phase 3)Study completedNCT00482677
What this trial is testing

Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Canadian Cancer Trials Group 562
Early research (Phase 1)Active Not RecruitingNCT04978727
What this trial is testing

A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma

Who this might be right for
MedulloblastomaGlioblastoma MultiformeAnaplastic Astrocytoma+5 more
Children's Oncology Group 35
Early research (Phase 1)Study completedNCT00770471
What this trial is testing

ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 24
Large-scale testing (Phase 3)Study completedNCT03776071
What this trial is testing

A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1

Who this might be right for
Glioblastoma
Denovo Biopharma LLC 260
Early research (Phase 1)Active Not RecruitingNCT04165941
What this trial is testing

Novel Gamma-Delta (γδ)T Cell Therapy for Treatment of Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Brain Tumor Adult
University of Alabama at Birmingham 22
Not applicableActive Not RecruitingNCT07674095
What this trial is testing

Assessment of a Large US EHR Database as Meeting FDA Fit-for-Purpose Requirements to Provide External Controls for Study BPM31510 in Participants With Glioblastoma

Who this might be right for
Glioblastoma
BPGbio 150
Testing effectiveness (Phase 2)Looking for participantsNCT07569042
What this trial is testing

A Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Malignant Neoplasm of Brain
Novelwise Pharmaceutical Corporation 15
Testing effectiveness (Phase 2)Study completedNCT00267592
What this trial is testing

Safety and Efficacy of Talampanel in Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Teva Branded Pharmaceutical Products R&D, Inc. 72
Testing effectiveness (Phase 2)Looking for participantsNCT06161974
What this trial is testing

Study of Olutasidenib and Temozolomide in HGG

Who this might be right for
High Grade GliomaAstrocytomaAstrocytoma, Grade III+16 more
Rigel Pharmaceuticals 60
Very early researchStudy completedNCT05432375
What this trial is testing

Study of Tinostamustine for Adjuvant Treatment of Glioblastoma

Who this might be right for
Glioblastoma Multiforme
Mundipharma Research Limited 10
Not applicableEnded earlyNCT02175745
What this trial is testing

18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas

Who this might be right for
Adult Anaplastic EpendymomaAdult Anaplastic OligodendrogliomaAdult Brain Stem Glioma+54 more
Erik Mittra 2
Early research (Phase 1)Study completedNCT02227901
What this trial is testing

Tipifarnib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma
National Cancer Institute (NCI) 19
Early research (Phase 1)Ended earlyNCT00895960
What this trial is testing

Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma

Who this might be right for
GlioblastomaCNS DiseaseBrain Diseases
M.D. Anderson Cancer Center 16
Early research (Phase 1)Active Not RecruitingNCT06894979
What this trial is testing

Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma

Who this might be right for
Childhood AstrocytomaChildhood Diffuse Intrinsic Pontine GliomaChildhood Diffuse Midline Glioma+2 more
Children's Oncology Group 54
Very early researchLooking for participantsNCT07485049
What this trial is testing

BGB-58067 in Newly Diagnosed Glioblastoma Patients With MTAP-Deleted Tumors

Who this might be right for
Glioblastoma (GBM)
Nader Sanai 78
Early research (Phase 1)Looking for participantsNCT07733674
What this trial is testing

Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Glioblastoma Multiforme (GBM)Pancreatic Ductal Adenocarcinoma (PDAC)
Radiomedix, Inc. 20
Testing effectiveness (Phase 2)Ended earlyNCT01898273
What this trial is testing

Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Cellectar Biosciences, Inc. 7
Next Page